On June 13, AMCP joined 24 patient and provider organizations in applauding the Supreme Court's unanimous ruling reversing the Fifth Circuit's decision in Alliance for Hippocratic Medicine et al. v FDA et al. AMCP and the undersigned organizations unequivocally support FDA's role in safeguarding patients, which has yielded approval of tens of thousands of crucial medications and devices for generations of Americans.
AMCP was honored to partner with The Skin of Color Society to develop two invaluable resources focusing on immune-mediated skin conditions — atopic dermatitis (AD) and alopecia areata (AA) — within the context of skin color, social determinants of health (SDOH), and health disparities. AMCP Director, Educational Programs/Grants Jennifer Evans, PharmD, BCACP, offers valuable insight into how to start bridging the gaps in care for these skin conditions in her latest blog post.
By Jennifer Evans, PharmD Director, Education Programs/Grants • 6/10/24
On May 29, AMCP released the following statement, which expresses concerns about the Illinois General Assembly's Healthcare protection Act (HB 5395). Passed on May 25, the bill restricts managed care pharmacists' ability to manage prescription drug benefits for millions of Illinoisans covered under the state’s Medicaid program, state employee group insurance, and fully insured commercial plans.
AMCP member advocates from across the country took to Capitol Hill to speak with lawmakers about ways to improve patient access to innovative new treatments as well as critical pharmacy legislation.
More than 3,500 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in New Orleans from April 15-18 for AMCP 2024, the industry’s largest and most impactful annual meeting. Attendees connected with like-minded professionals, discussed the important trends impacting their work, and expanded their horizons through cutting-edge education sessions.
On Feb. 29, 2024, the Centers for Medicare and Medicaid Services (CMS) issued The Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents. AMCP submitted comments in response to this Model Documents on April 29, 2024.
AMCP and the AMCP Foundation are pleased to announce winners of this year’s awards that recognize individuals who have made significant contributions to the organizations and managed care pharmacy. The awards are presented annually in the spring.